Across TCGA pan-cancer cohorts, NTF4 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated NTF4 data layer compared with 28 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher NTF4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NTF4 expression acts as an unfavorable survival marker.

BLCA and KICH are the cancer types where NTF4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.174	0.720	<.001	24	view →
KICH	DFS	Median	All	0.102	0.848	.004	13	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: NTF4 tumor-vs-normal RNA expression · all NTF4 data types